Transparent corporate social responsibility ratings to help you change the world.
LEARN ABOUT A COMPANY'S SUSTAINABILITY
User login form 2012
SUBSCRIBE NOW, for all the benefits.
-
BENCHMARK companies'
sustainability in 12 sub-categories. -
ROLLBACK and view CSR ratings
over time (pro level). -
EXPORT customized search results
to Excel. -
VIEW companies' CSR sites and
underlying data from many sources.
ANNUAL PLAN, 4 MONTHS FREE
Profile unified block 2012
PROFILE TOOL
CSRHub user average |
EDIT | |
| PRIORITIES | ||
| Community | 2.6 | |
| Employees | 2.8 | |
| Environment | 3.7 | |
| Governance | 2.9 | |
SPECIAL ISSUES
No special issues for this profile.
 |
Dendreon Corporation |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
     
Dendreon Corporation, a Seattle-based biotechnology company, is focused on the discovery, development and commercialization of novel therapeutics to fight cancer. Dendreon specializes in antigen identification, engineering and cell processing to produce Active Cellular Immunotherapy (ACI) product candidates designed to stimulate an immune response. Dendreon's lead ACI product candidate, known as PROVENGE (sipuleucel-T) is in late-stage development for the treatment of men with metastatic, androgen-independent prostate cancer.
Basic corporate social responsibility ratings
Data sources for this company
Ratings historySubcategory CSR ratings
Original data values
Name variants
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
